NEW YORK Enfamil Lipil infant formula outperforms Similac Advance when it comes to a child’s mental and visual impairment, according to Enfamil’s advertising claims.
However, the National Advertising Division of the Better Business Bureau doesn’t agree. The ad industry’s self-regulatory forum has taken issue with such claims that have appeared in print ads, point-of-sale materials as well as on Enfamil Lipil packaging.
Enfamil has also distributed coupons that show a chart inviting consumers to compare the differences between Enfamil Lipil and Abbott Nutrition’s Similac Advance.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in